"I have hope again," says Juanita Vernon as the 52-year-old tearfully discusses her feelings about being able to access incredibly costly medication that had drastically improved her quality of life.
Ms Vernon has the genetic condition spinal muscular atrophy (SMA) and was able to walk and live reasonably independently for much of her life, but a few years ago she started losing strength and mobility.
